Literature DB >> 12874322

Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice.

Matthew B Lawrenz1, R Mark Wooten, James F Zachary, Scott M Drouin, Janis J Weis, Rick A Wetsel, Steven J Norris.   

Abstract

Mice deficient in complement component C3 (C3(-/-)) and syngeneic C57BL/6 control mice were challenged with Borrelia burgdorferi to determine the role of complement in immune clearance and joint histopathology during experimental Lyme borreliosis. Tibiotarsal joint, ear, and heart tissues were monitored for spirochete numbers at 2, 4, 8, and 12 weeks postinoculation with 10(5) B. burgdorferi B31 clone 5A4 by using quantitative real-time PCR. The spirochete load in joint and ear tissue remained higher in the C3(-/-) mice than in the wild-type counterparts throughout the 12-week study, whereas the numbers in heart tissue of both groups of mice decreased substantially at 8 to 12 weeks postinfection. Histopathology scores for joint tissue were generally higher in the C3(-/-) mice compared to C57BL/6 controls at 2 and 4 weeks postinfection, which may reflect the presence of higher numbers of bacteria in the joints at these early time points. Levels of anti-B. burgdorferi immunoglobulin G tended to be reduced in the C3(-/-) mice compared to control mice. Furthermore, a 5.5-fold-lower number of the complement-sensitive Borrelia garinii was needed to infect C3(-/-) mice compared to C57BL/6 mice, indicating that its sensitivity to complement is one barrier to infection of the mouse model by B. garinii. These results indicate that the complement system may be important in controlling the early dissemination and progression of B. burgdorferi infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874322      PMCID: PMC165993          DOI: 10.1128/IAI.71.8.4432-4440.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease.

Authors:  H M Feder; M A Gerber; S W Luger; R W Ryan
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

2.  Comparison of two laboratory methods for the determination of serum resistance in Borrelia burgdorferi isolates.

Authors:  P Kraiczy; K P Hunfeld; S Breitner-Ruddock; R Würzner; G Acker; V Brade
Journal:  Immunobiology       Date:  2000-01       Impact factor: 3.144

3.  Correlation between plasmid content and infectivity in Borrelia burgdorferi.

Authors:  J E Purser; S J Norris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB.

Authors:  J L Coleman; R C Rogers; J L Benach
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

5.  Borrelia burgdorferi--induced oxidative burst, calcium mobilization, and phagocytosis of human neutrophils are complement dependent.

Authors:  J Suhonen; K Hartiala; H Tuominen-Gustafsson; M K Viljanen
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

6.  A Lyme borreliosis cycle in seabirds and Ixodes uriae ticks.

Authors:  B Olsén; T G Jaenson; L Noppa; J Bunikis; S Bergström
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

Review 7.  Complement defense mechanisms.

Authors:  S Tomlinson
Journal:  Curr Opin Immunol       Date:  1993-02       Impact factor: 7.486

8.  Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.

Authors:  S J Norris; C J Carter; J K Howell; A G Barbour
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

9.  Differences of two Borrelia burgdorferi strains in complement activation and serum resistance.

Authors:  V Brade; I Kleber; G Acker
Journal:  Immunobiology       Date:  1992-09       Impact factor: 3.144

10.  Western blotting in the serodiagnosis of Lyme disease.

Authors:  F Dressler; J A Whalen; B N Reinhardt; A C Steere
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

View more
  23 in total

1.  Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts.

Authors:  Ashley L Marcinkiewicz; Alan P Dupuis; Maxime Zamba-Campero; Nancy Nowak; Peter Kraiczy; Sanjay Ram; Laura D Kramer; Yi-Pin Lin
Journal:  Cell Microbiol       Date:  2019-01-07       Impact factor: 3.715

Review 2.  Complement Evasion by Lyme Disease Spirochetes.

Authors:  Jon T Skare; Brandon L Garcia
Journal:  Trends Microbiol       Date:  2020-05-29       Impact factor: 17.079

3.  Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.

Authors:  Jennifer A Caine; Yi-Pin Lin; Julie R Kessler; Hiromi Sato; John M Leong; Jenifer Coburn
Journal:  Cell Microbiol       Date:  2017-09-26       Impact factor: 3.715

4.  Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi.

Authors:  M B Lawrenz; J M Hardham; R T Owens; J Nowakowski; A C Steere; G P Wormser; S J Norris
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 5.  Biology of infection with Borrelia burgdorferi.

Authors:  Kit Tilly; Patricia A Rosa; Philip E Stewart
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

6.  Mice lacking CD21 and CD35 proteins mount effective immune responses against Borrelia burgdorferi infection.

Authors:  Amanda C Jacobson; Ying Ma; James F Zachary; Janis J Weis; John H Weis
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

7.  Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production.

Authors:  Peter N Lalli; Michael G Strainic; Feng Lin; M Edward Medof; Peter S Heeger
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

8.  Non-anticoagulant Heparin as a Pre-exposure Prophylaxis Prevents Lyme Disease Infection.

Authors:  Yi-Pin Lin; Yanlei Yu; Ashley L Marcinkiewicz; Patricia Lederman; Thomas M Hart; Fuming Zhang; Robert J Linhardt
Journal:  ACS Infect Dis       Date:  2020-01-30       Impact factor: 5.084

Review 9.  Lyme disease: aetiopathogenesis, factors for disease development and control.

Authors:  I R Kean; K L Irvine
Journal:  Inflammopharmacology       Date:  2012-10-31       Impact factor: 4.473

10.  Borrelia burgdorferi binding of host complement regulator factor H is not required for efficient mammalian infection.

Authors:  Michael E Woodman; Anne E Cooley; Jennifer C Miller; John J Lazarus; Kathryn Tucker; Tomasz Bykowski; Marina Botto; Jens Hellwage; R Mark Wooten; Brian Stevenson
Journal:  Infect Immun       Date:  2007-04-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.